PCR test – Page 25 – Communicable Diseases Research

The value of anal swab RT-PCR for COVID-19 diagnosis in adult Indonesian patients

성인 인도네시아 환자에서 COVID-19 진단을 위한 항문 면봉 RT-PCR의 가치

Observational Study

Published on 2021-05-012022-09-11
Journal: BMJ open gastroenterology [Category] SARS, 임상, 치료기술,

Validation testing to determine the sensitivity of lateral flow testing for asymptomatic SARS-CoV-2 detection in low prevalence settings: Testing frequency and public health messaging is key

낮은 유병률 설정에서 무증상 SARS-CoV-2 감지에 대한 측면 흐름 테스트의 민감도를 결정하기 위한 검증 테스트: 테스트 빈도 및 공중 보건 메시지가 핵심입니다.

Research Article

Published on 2021-04-292022-09-10
Journal: PLoS Biology [Category] MERS, SARS, 진단, 치료기술,

Efficacy and safety of nelfinavir in asymptomatic and mild COVID-19 patients: a structured summary of a study protocol for a multicenter, randomized controlled trial

무증상 및 경증 COVID-19 환자에 대한 nelfinavir의 효능 및 안전성: 다기관, 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약

Letter

Published on 2021-04-282022-09-10
Journal: Trials [Category] SARS, 임상, 치료기술,

[키워드] 1:1 Administered administration adverse event adverse events age all-cause mortality ALT Analysis anticipated Antigen antiviral efficacy AST Asymptomatic asymptomatic patients blinded blinded outcome assessment Blinding blood glucose body temperature both group both groups capture caused childbearing potential clearance clinical Clinical efficacy clinical examinations Clinical symptoms clinical trial clinical trials comparator Patients condition Consent contraceptive method Controlled clinical trial cough COVID-19 creatinine creatinine clearance dataset Day defervescence diabete diabetes diarrhea discretion dissemination distribution drug element enrolled enrolment evaluate event exclusion criteria exploratory Factor female patient Fever Frequency Glucose group hazard ratio Hemophiliac Hemorrhagic history HIV infection hospital hypersensitivity incidence incidence rate Inclusion inclusion and exclusion criteria inclusion criteria Infection Informed consent initial investigator investigator-initiated investigators Japan Japanese LAMP limit log-rank test male Mild mild COVID-19 patient Mild disease mixed-effects model multicenter Nasopharyngeal swab Negative conversion Negative PCR nelfinavir null hypothesis number objective Open-label outcome oxygen Oxygen administration p value parallel group parameter participant Patient patients with asymptomatic PCR PCR test Pneumonia power Pregnancy primary endpoint Primary outcome principal investigator Probability probability distribution protocol random randomization Randomized Randomized controlled trial Registered registry reported required respiratory tract rifampicin room air safety endpoint Saliva saliva samples Sample size SARS-CoV-2 SARS-CoV-2 vaccination secondary efficacy endpoint serious complication serum creatinine severity specimen Standard status study period Study protocol supplementary material survival survival function Symptom symptomatic symptomatic COVID-19 Symptomatic treatment the log-rank test Three times daily Treatment treatment for HIV treatment period Trial Trial registration two-sided Unsuitable Viral viral dynamics Viral load virus was determined website Withdrawal withdrawal of consent
[DOI] 10.1186/s13063-021-05282-w PMC 바로가기 [Article Type] Letter

Estimating the effectiveness of routine asymptomatic PCR testing at different frequencies for the detection of SARS-CoV-2 infections

SARS-CoV-2 감염 감지를 위한 다양한 빈도의 일상적인 무증상 PCR 검사의 효과 추정

Research Article

Published on 2021-04-272022-09-01
Journal: BMC Medicine [Category] MERS, 진단,

[키워드] Asymptomatic Asymptomatic case Asymptomatic cases asymptomatic infection Bayesian Care Course COVID-19 dataset detect Effectiveness estimates Frequency healthcare worker Healthcare workers help hospital infected individual infected individuals Infection medical staff Nasopharyngeal swab notification outbreak PCR PCR test PCR testing peaked performed populations positive PCR test Presymptomatic infections Prevent Probability proportion provided Result returned routine RT-PCR SARS-CoV-2 SARS-COV-2 infection sensitivity statistical model supplementary material symptom onset symptomatic case symptomatic cases symptomatic infection Symptoms test results Test sensitivity twice weekly Vulnerable populations
[DOI] 10.1186/s12916-021-01982-x PMC 바로가기 [Article Type] Research Article

Seroprevalence of SARS-CoV-2 Infection and Adherence to Preventive Measures in Cuenca, Ecuador, October 2020, a Cross-Sectional Study

Article

Published on 2021-04-272022-10-29
Journal: International Journal of Environmental Research an [Category] COVID-19, MERS, SARS,

Time variation in the probability of failing to detect a case of polymerase chain reaction testing for SARS-CoV-2 as estimated from a viral dynamics model

바이러스 역학 모델에서 추정한 SARS-CoV-2에 대한 중합효소연쇄반응 검사 사례를 감지하지 못할 확률의 시간 변화

Life Sciences–Mathematics interface

Published on 2021-04-212022-09-10
Journal: Journal of the Royal Society Interface [Category] MERS, SARS, 치료기술,

SARS-CoV-2 Antibody Screening in Healthcare Workers in Non-Infectious Hospitals in Two Different Regions of Southern Poland (Upper Silesia and Opole Voivodeships): A Prospective Cohort Study

폴란드 남부의 서로 다른 두 지역(Upper Silesia 및 Opole Voivodeships)의 비감염성 병원 의료 종사자를 대상으로 한 SARS-CoV-2 항체 검사: 전향적 코호트 연구

Article

Published on 2021-04-202022-09-10
Journal: International Journal of Environmental Research an [Category] MERS, SARS, 치료기술,

[키워드] antibody screening Asymptomatic benefit blood collection coronavirus coronavirus SARS-CoV-2 COVID-19 detection determine different time point ELISA test emergency wards evaluated had no HCW HCWs health-care professionals healthcare healthcare worker Healthcare workers hospital Hospital environment Host human coronavirus IgA IgG IgM IgM/IgG immunoglobulins individual Infection Local negative RT-PCR New coronavirus non-infectious patients PCR test PCR testing performed Poland Population positive Prevalence Prospective reduce Region risk RT-PCR RT-PCR test RT-PCR testing sampling SARS-CoV-2 SARS-COV-2 infection Screening semi-quantitative ELISA sera serologic responses serological surveillance Seropositivity socio-demographic Spread Symptoms symptoms of infection test results university university hospital upper Volunteer worker
[DOI] 10.3390/ijerph18084376 PMC 바로가기 [Article Type] Article

SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)

영국에서 항체 음성 의료 종사자와 비교한 항체 양성 환자의 SARS-CoV-2 감염률: 대규모, 다기관, 전향적 코호트 연구(SIREN)

Multicenter Study

Published on 2021-04-172022-09-11
Journal: Lancet (London, England) [Category] MERS, SARS, 진단, 치료기술,

[키워드] 95% CI adjusted Analysis antibody Antibody test antibody test) Antibody testing assigned baseline clinically Cohort cohorts COVID-19 defined Department determined by effective eligible England enrolled enrolment Evidence first positive Follow-up frailty future infection had no hazard health-care hierarchy hospital Immunity incidence incidence density incidence rate include Increased individual individuals induce Infection infection rate infection rates infection with SARS-CoV-2 infections Linked data lower risk median median interval multicentre participant Participants PCR PCR positive PCR test PCR testing PCR tests PCR-confirmed Poisson distribution positive positive PCR positive PCR test Potential Primary infection Primary outcome prospective cohort study protective effect Public Health England questionnaire Questionnaires rate ratios recruited Region Reinfection risk SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 PCR Scottish Seroconversion Support Symptom symptomatic and asymptomatic UK Government was done was used were excluded
[DOI] 10.1016/S0140-6736(21)00675-9 PMC 바로가기 [Article Type] Multicenter Study

Screening of severe acute respiratory syndrome coronavirus-2 infection during labor and delivery using polymerase chain reaction and immunoglobulin testing

중합효소연쇄반응과 면역글로불린 검사를 이용한 분만 중 중증급성호흡기증후군 코로나바이러스-2 감염 검사

Article

Published on 2021-04-152022-09-11
Journal: Life sciences [Category] MERS, SARS, 진단, 치료기술,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus-2 Admission Asymptomatic Chain Reaction coronavirus Coronavirus 2019 coronavirus disease Coronavirus-2 COVID-19 Evidence evidence of groups hospital Hospital admission Immunoglobulin Immunoglobulin G immunoglobulins Infection intensive care intensive care unit labor Labor and delivery Laboratory Maternal mild clinical symptom mild clinical symptoms mother Newborn no significant difference no significant differences on admission outcome outcomes PCR PCR test polymerase chain polymerase chain reaction positive PCR pregnant women Prevalence required respiratory SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 infections SARS-CoV-2 PCR screened Screening serological test serum immunoglobulin serum immunoglobulins Severe acute respiratory syndrome severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus-2 Spanish women
[DOI] 10.1016/j.lfs.2021.119200 PMC 바로가기 [Article Type] Article

Multicentre randomised double-blinded placebo-controlled trial of favipiravir in adults with mild COVID-19

경증 COVID-19 성인을 대상으로 한 favipiravir의 다기관 무작위 이중 맹검 위약 대조 시험

Article

Published on 2021-04-142022-09-11
Journal: BMJ Open [Category] 임상,

[키워드] 1:1 Affair approved blinded by mouth caused clinical clinical trials control group Coronavirus infection COVID-19 COVID-19 sample Cox proportional hazard regression decrease diagnosed disease onset double-blind double-blinded dropout rate Efficacy and safety Eligible participants Ethics evaluate the effect evaluated Evidence Favipiravir follow-up period followed by hazard ratio healthcare hypothesise Infectious diseases institutional review board intention to treat International King lack limit medication men Mild Ministry of Health mouth nonpregnant Novel coronavirus outbreak outcome participant Patient PCR PCR test peer-reviewed per day physician Placebo placebo-controlled trial positive potential therapy primary analysis population Primary outcome randomised Randomised trial recruit recruited registration number registry reported required Respiratory illness SARS-CoV-2 subject swab sample symptomatic patient Symptomatic patients the timing therapeutic agent Therapeutics therapy treat treated Treatment Virology virus virus clearance women
[DOI] 10.1136/bmjopen-2020-047495 PMC 바로가기 [Article Type] Article